Related Experiment Video
Updated: Jun 30, 2026

The Successive Alleys Test of Anxiety in Mice and Rats
Published on: June 17, 2013
Psychotropic effects of angiotensin II and III in rats: locomotor and exploratory vs cognitive behaviour
J J Braszko1, K Wiśniewski, G Kupryszewski
1Department of Pharmacology, Medical Academy, Białystok, Poland.
This study examines how two brain-active peptides, angiotensin II and III, influence movement, exploration, and memory processes in rats when administered directly into the brain. The findings indicate these substances boost physical activity and enhance specific types of learning and memory retention.
Area of Science:
- Neuropharmacology research involving angiotensin II signaling pathways
- Behavioral neuroscience and cognitive psychology
Background:
The precise role of brain-derived peptides in modulating complex behavioral states remains poorly understood. Prior research has shown that peripheral hormonal systems often interact with central nervous system functions. That uncertainty drove interest in how specific molecules influence movement and cognitive processes. Existing literature frequently focuses on cardiovascular regulation rather than behavioral outcomes. No prior work had fully resolved the distinct effects of these peptides on memory consolidation versus retrieval. Scientists have long debated whether these substances act primarily as neuromodulators. This gap motivated a closer look at their impact on spatial and avoidance tasks. Previous studies often utilized systemic administration, which complicates the interpretation of direct brain effects.
Purpose Of The Study:
The aim of this study is to characterize the psychotropic effects of two specific peptides on behavioral and cognitive outcomes in rats. Researchers sought to determine how these molecules influence locomotor activity and exploration. The study also investigates the impact of these peptides on memory consolidation and retrieval processes. A key motivation was to distinguish between different types of motivated behaviors. The authors aimed to clarify whether these substances affect appetitive versus aversive memory tasks. This work addresses the need for understanding central peptide signaling in behavioral regulation. The researchers hypothesized that these peptides would modulate motor responses and learning rates. By testing these variables, the study provides insight into the functional role of these peptides in the brain.
Main Methods:
The review approach synthesized data from experiments involving intracerebroventricular administration of peptides in rat models. Investigators utilized an open field apparatus to quantify exploratory patterns and physical movement. They also employed an electromagnetic field motimeter to verify locomotor changes under different environmental conditions. Pharmacological challenges involved intraperitoneal injections of apomorphine and amphetamine to assess stereotyped responses. Cognitive assessments included an appetitively reinforced spatial discrimination task within a T-maze. Researchers evaluated memory consolidation and retrieval through specific timing of peptide delivery relative to learning sessions. A shuttle-box setup served to monitor the acquisition of conditioned avoidance responses over one week. Finally, passive avoidance testing provided a framework for measuring memory retention through re-entry latencies.
Main Results:
The strongest finding indicates that one nanomole of the peptides significantly increased exploratory and locomotor activity in open field settings. These substances remarkably prolonged re-entry latencies by five-fold in passive avoidance situations. Both peptides enhanced stereotyped behaviors when combined with apomorphine at two milligrams per kilogram. Similar potentiation occurred with amphetamine at six point five milligrams per kilogram. The peptides improved memory consolidation for spatial tasks but failed to impact retrieval in the T-maze. Administration prior to training sessions increased the rate of conditioned avoidance acquisition over seven days. These results demonstrate a clear, significant influence on both motor output and memory formation. The data confirm that these peptides modulate behavioral responses differently depending on the specific cognitive or physical task.
Conclusions:
The authors propose that both peptides facilitate memory consolidation in appetitive spatial tasks. Their findings suggest these compounds do not influence the retrieval phase of such memory processes. The researchers indicate that these molecules significantly accelerate the acquisition of conditioned avoidance responses. Synthesis and implications suggest that the peptides exert a potent effect on aversive memory retrieval. The data show a five-fold increase in re-entry latencies during passive avoidance testing. These results imply a clear distinction between the modulation of consolidation and retrieval mechanisms. The authors conclude that these substances act as significant behavioral stimulants in specific contexts. Their work highlights the complex interaction between peptide signaling and memory performance in rodents.
Frequently Asked Questions
The researchers propose that these peptides enhance memory consolidation and retrieval. Specifically, they observed a five-fold increase in re-entry latencies during passive avoidance tests, indicating improved memory for aversively motivated behaviors compared to control groups.
The study utilized an open field apparatus to measure physical movement. In contrast, the electromagnetic field motimeter failed to detect significant changes in locomotor activity following the administration of these specific brain-active peptides.
The authors administered one nanomole of the peptides directly into the brain via the intracerebroventricular route. This specific delivery method is necessary to bypass the blood-brain barrier and isolate the central effects of the substances from peripheral cardiovascular influences.
The peptides significantly amplified stereotyped behaviors induced by apomorphine and amphetamine. These findings suggest that the substances interact with dopaminergic pathways to modulate motor output, whereas control subjects showed lower levels of stereotypy.
The authors measured the rate of acquisition for conditioned avoidance responses over a seven-day period. They found that pre-learning administration of the peptides improved the speed of learning compared to untreated animals.
The researchers suggest that these peptides act as neuromodulators of cognitive and motor functions. They claim that the observed behavioral shifts provide evidence for the involvement of these molecules in central nervous system processing.

